dehydroepiandrosterone has been researched along with Leukemia in 7 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Excerpt | Relevance | Reference |
---|---|---|
" Here, we examined the metabolic changes induced by 2-deoxyglucose (2-DG), a glycolysis inhibitor, in leukemia cells by metabolome analysis." | 7.79 | Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose. ( Goto, M; Gotou, M; Hanamura, I; Horio, T; Imamura, A; Ishikawa, T; Mihara, H; Miwa, H; Mizuno, S; Mizutani, M; Nitta, M; Shikami, M; Takahashi, M; Tsunekawa-Imai, N; Wakabayashi, M; Watarai, M; Yamamoto, H, 2013) |
" Here, we examined the metabolic changes induced by 2-deoxyglucose (2-DG), a glycolysis inhibitor, in leukemia cells by metabolome analysis." | 3.79 | Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose. ( Goto, M; Gotou, M; Hanamura, I; Horio, T; Imamura, A; Ishikawa, T; Mihara, H; Miwa, H; Mizuno, S; Mizutani, M; Nitta, M; Shikami, M; Takahashi, M; Tsunekawa-Imai, N; Wakabayashi, M; Watarai, M; Yamamoto, H, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miwa, H | 1 |
Shikami, M | 1 |
Goto, M | 1 |
Mizuno, S | 1 |
Takahashi, M | 1 |
Tsunekawa-Imai, N | 1 |
Ishikawa, T | 1 |
Mizutani, M | 1 |
Horio, T | 1 |
Gotou, M | 1 |
Yamamoto, H | 1 |
Wakabayashi, M | 1 |
Watarai, M | 1 |
Hanamura, I | 1 |
Imamura, A | 1 |
Mihara, H | 1 |
Nitta, M | 1 |
SUARDI, L | 1 |
GALLAGHER, TF | 1 |
HELLMAN, L | 1 |
ZUMOFF, B | 1 |
MILLER, DG | 1 |
Goncharova, ND | 1 |
Goncharov, NP | 1 |
Lebedev, VN | 1 |
Lapin, BA | 1 |
Bolme, P | 1 |
Borgström, B | 1 |
Carlström, K | 1 |
Szatmári, E | 2 |
Fehér, T | 2 |
7 other studies available for dehydroepiandrosterone and Leukemia
Article | Year |
---|---|
Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Topics: Acetyl Coenzyme A; AMP-Activated Protein Kinases; Carnitine O-Palmitoyltransferase; Cell Line, Tumor | 2013 |
[Preliminary results of the study of metabolites in leukemia. IV. Urinary elimination of total and fractional 17-ketosteroids following administration of testosterone and dehydroepiandrosterone].
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Androgens; Body Fluids; Dehydroepiandrosterone; Humans; Le | 1957 |
STEROID HORMONE METABOLISM IN CHRONIC MYELOGENOUS LEUKEMIA.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Androgens; Androsterone; Busulfan; Cyclophosphamide; Dehyd | 1965 |
[Plasma concentrations of aldosterone and dehydroepiandrosterone in leukemia patients].
Topics: Adult; Aged; Aldosterone; Dehydroepiandrosterone; Female; Humans; Leukemia; Male; Middle Aged | 1984 |
Longitudinal study of adrenocortical function following allogeneic bone marrow transplantation in children.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex; Adrenocorticotropic Hormone; Androstenedio | 1995 |
[Excretion of 17-ketosteroid fractions in leukemia patients following prednisolone therapy].
Topics: 17-Ketosteroids; Adolescent; Adult; Aged; Androsterone; Dehydroepiandrosterone; Etiocholanolone; Fem | 1971 |
[Excretion of 17-ketosteroid fractions in leukemic patients following ACTH therapy].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; An | 1966 |